Park Ha Biological Technology Co., Ltd. (PHH) Stock Overview
Explore Park Ha Biological Technology Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Park Ha Biological Technology Co., Ltd. (PHH)
Key Financials
Key Financials
Market Cap
10M
P/E Ratio
21.04
EPS (TTM)
$-0.72
ROE
0.38%
PHH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Park Ha Biological Technology Co., Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PHH on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $6.68 for the NASDAQ listing.
Key metrics behind Park Ha Biological Technology Co., Ltd.'s NASDAQ-traded stock include a P/E ratio of 21.04 and a market capitalization of 10M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PHH on the NASDAQ.